Physician

Adam J. Rowen, M.D.

According to 2025 Medicare claims, Adam Rowen, M.D. (NPI: 1386729325) practices pulmonary disease in the Newark, NJ market, with the plurality of this provider's patient population coming from Union, NJ. Rowen uses personal NPI as billing NPI and primary practice location at 07202-2111.

Rowen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 56 traditional Medicare patients, billed 218 HCPCS/CPT codes, and received $10,552 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 247 prescription claims across 41 beneficiaries totaling $128,957 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 11 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $48,014 to $10,552. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,049 to $801.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	159	975	$48,014
2016	170	849	$41,528
2017	158	852	$42,679
2018	128	667	$33,450
2019	112	519	$23,530
2020	93	382	$18,419
2021	75	293	$17,864
2022	65	221	$11,030
2023	66	225	$10,006
2024	56	218	$10,552

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	663	$169,720
2016	71	571	$165,923
2017	83	617	$163,268
2018	78	576	$155,732
2019	68	498	$170,299
2020	57	356	$168,934
2021	53	321	$261,377
2022	55	332	$188,056
2023	52	258	$172,366
2024	41	247	$128,957

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	57	$1,843
2016	N/R	69	$2,470
2017	N/R	39	$1,801
2018	N/R	21	$1,372
2019	N/R	N/R	N/R
2020	N/R	35	$899
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$666

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	17	25	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	23	59	$69
94727	Test to determine lung volumes using gas dilution or washout	20	20	$10
94060	Test to measure expiratory airflow and volume changes before and after medication administration	20	20	$8
94729	Test to examine how well the lungs exchange gases	20	20	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	4,200	$86,756
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	22	930	$19,083
Breo Ellipta	Fluticasone/Vilanterol	18	960	$11,854
Albuterol Sulfate Hfa	Albuterol Sulfate	21	961	$1,226
Valsartan	Valsartan	17	1,530	$657

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$666

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam J. Rowen, M.D.?

Tedicare shows public-source Medicare data for Adam J. Rowen, M.D. (NPI 1386729325), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam J. Rowen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam J. Rowen, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Adam J. Rowen, M.D. have Open Payments data?

Adam J. Rowen, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.